Matthew Herper covers medical innovation — both its promise and its perils. CHICAGO — Ivonescimab, a drug that combines the activity of two of the best-selling cancer medicines, reduced the risk of ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

We've had a lot of destruction here, and it doesn't mean that we have to just go back and say, well, let's rebuild it as it was." ...

CEO Mark Goldsmith says Revolution Medicines will submit pancreatic cancer drug daraxonrasib for FDA approval soon.

Trump officials are disregarding the Biden administration's detailed pandemic plans in favor of their own strategy.

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation and legislation. He is also the author of the morning Pharmalittle newsletter ...

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for email editions ...

President Trump had another medical exam on Tuesday, putting his health under renewed public scrutiny after he has worked to ...

Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer ...

President Trump's cuts to foreign aid probably hampered the detection of the Ebola outbreak and the response to it.

Massachusetts Attorney General Andrea Joy Campbell is suing UnitedHealth Group’s insurance subsidiary, UnitedHealthcare, alleging the company intentionally made low-income older adults appear sicker ...

But some patients and their families, worried by misinformation around Covid-19 vaccines, are insisting on getting blood ...